site sponsored by
Tag Archive | "drug-safety"
&h=57&w=100&zc=1&q=80" alt="GSK Kills the FDA Beast! Avandia Lives Another Day. Stay Tuned for DTC." class="th" />
Tags: airplanes, automobiles, avandia, comparison, drug-safety, drugs, gsk, lieutenant, market, marketplace, recommendations, Regulatory, scene, senate
GSK Kills the FDA Beast! Avandia Lives Another Day. Stay Tuned for DTC.
Posted on 15 July 2010
Posted in Web MarketingComments (0)
Tags: conclusion, congress, data, drug-safety, from-the-market, light, public, says-the-times, times
GSK’s Coverup of Avandia’s Heart Risk Data: Is This How the Entire Industry Views Its Repsonsibility to Patients?
Posted on 13 July 2010
Posted in Web MarketingComments (0)
&h=57&w=100&zc=1&q=80" alt="Can Your Read This "Fair Balance" on Race With Insulin Twitter Page, or Is It Just Me Having Problems?" class="th" />
Tags: conferences, drug-safety, insulin-twitter, levemir, medical, nordisk, podcast, point-out-how, race, safety, think-the-fda, twitter, vision-problems
Can Your Read This "Fair Balance" on Race With Insulin Twitter Page, or Is It Just Me Having Problems?
Posted on 16 June 2010
Posted in Web MarketingComments (0)
&h=57&w=100&zc=1&q=80" alt="Despite Its Social Media Expertise, J&J Fails to Engage in Conversation with Critics" class="th" />
Tags: conversation, director, drug-safety, facebook, government, jnj btw, mcneil, Regulatory, Social Media, weldon
Despite Its Social Media Expertise, J&J Fails to Engage in Conversation with Critics
Posted on 18 May 2010
Posted in Web MarketingComments (0)
&h=57&w=100&zc=1&q=80" alt="What If, God Forbid, Sally Field Broke Her Leg?" class="th" />
Tags: boniva, celebrity, celebrity endorsement, crowd, drug, drug-safety, drugs, medicine, reclast, remineralized, Social Media, study, study-adds
What If, God Forbid, Sally Field Broke Her Leg?
Posted on 27 March 2010
Posted in Traditional StrategiesComments (0)
&h=57&w=100&zc=1&q=80" alt="Are Pharma Marketers Drug Pushers?" class="th" />
Tags: book, chairman, drug-safety, DTC, dtc advertising, myers-squibb, sales, search, such-as-johnson, user, word
Are Pharma Marketers Drug Pushers?
Posted on 25 March 2010
Posted in Traditional StrategiesComments (0)
&h=57&w=100&zc=1&q=80" alt="PatientsLikeMe Reports High Rate of Adverse Event Reporting Among Its Members" class="th" />
Tags: drug-safety, entire, establishment, given-the-right, improve-health, internet, partnership, patientslikeme, Social Media, words
PatientsLikeMe Reports High Rate of Adverse Event Reporting Among Its Members
Posted on 02 March 2010
Posted in Web MarketingComments (0)
Tags: appear-before, avandia, back-as-far, congress, drug-safety, gsk, institute, medication, patient-deaths, recall-more, senate, three-quarters, top-executives, were-received, yearly-death
If Drugs Were Like Automobiles
Posted on 25 February 2010
Posted in Traditional StrategiesComments (0)
Tags: communications, cpi, critical, critical-path, development, drug-safety, events, funding, health, initiative, journal, medical, science, translation
Is the Critical Path Initiative in Critical Condition? Is the Advancing Regulatory Science Initiative Replacing the Critical Path?
Posted on 23 February 2010
Posted in RegulatoryComments (0)
&h=57&w=100&zc=1&q=80" alt="Steve Nissen to GSK (and FDA): "Put Patients First! It’s Time to Pull Avandia from the Market."" class="th" />
Tags: data, drug, drug-safety, epidemiology, fda, imagination, manuscript, market, office, people, surveillance
Steve Nissen to GSK (and FDA): "Put Patients First! It’s Time to Pull Avandia from the Market."
Posted on 22 February 2010
Posted in Web MarketingComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Let’s Just Spread This Deal Out All Over the Paper, Why Don’t We?
- Design: Flash-banner-eyebrow nightmare
- Even After Patent Cliff, Pfizer Is Undervalued
- Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
- FTC: âTide May Be Turningâ On Pay-To-Delay Deals
- Celgene Beats and Raises Guidance
- Who is Killing the Pharmaceutical Sales Position?
- Snafi – HCP print ad in the UAE
- Hospira plans big study for new Epogen biosimilar
- New from OSI / Astellas
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
